KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Tax Provisions (2017 - 2018)

Historic Tax Provisions for Palvella Therapeutics (PVLA) over the last 4 years, with Q4 2018 value amounting to -$164000.0.

  • Palvella Therapeutics' Tax Provisions fell 21388.89% to -$164000.0 in Q4 2018 from the same period last year, while for Sep 2019 it was -$164000.0, marking a year-over-year decrease of 400000.0%. This contributed to the annual value of $164000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Palvella Therapeutics reported Tax Provisions of -$164000.0 as of Q4 2018, which was down 21388.89% from -$148000.0 recorded in Q2 2018.
  • In the past 5 years, Palvella Therapeutics' Tax Provisions registered a high of $814000.0 during Q2 2017, and its lowest value of -$164000.0 during Q4 2018.
  • For the 4-year period, Palvella Therapeutics' Tax Provisions averaged around $110647.8, with its median value being $40441.0 (2015).
  • The largest annual percentage gain for Palvella Therapeutics' Tax Provisions in the last 5 years was 11818.18% (2018), contrasted with its biggest fall of 21388.89% (2018).
  • Over the past 4 years, Palvella Therapeutics' Tax Provisions (Quarter) stood at -$18.0 in 2014, then skyrocketed by 908016.67% to $163425.0 in 2015, then dropped by 11.89% to $144000.0 in 2017, then plummeted by 213.89% to -$164000.0 in 2018.
  • Its last three reported values are -$164000.0 in Q4 2018, -$148000.0 for Q2 2018, and $144000.0 during Q4 2017.